Maintenance of AP-2- dependent functional activities of Nef restricts pathways of immune escape from CD8 T lymphocyte responses

Journal of Virology

Volumn 92, Issue 5, 2018, Pages

  Schouest, Blake ^a   Weiler, Andrea M ^b   Janaka, Sanath Kumar ^c   Myers, Tereance A ^a   Das, Arpita ^a   Wilder, Sarah C ^a   Furlott, Jessica ^b   Baddoo, Melody ^d   Flemington, Erik K ^d   Rakasz, Eva G ^b   Evans, David T ^b,c   Friedrich, Thomas C ^b,e   Maness, Nicholas J ^a,d  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

CD4; Evolution; Major histocompatibility complex; SERINC; Simian immunodeficiency virus; Tetherin; Viral escape

Indexed keywords

BONE MARROW STROMAL ANTIGEN 2; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NEF PROTEIN; TRANSCRIPTION FACTOR AP 2; CELL SURFACE RECEPTOR; EPITOPE; HLA ANTIGEN CLASS 1; MAMU-B 01 ANTIGEN, MACACA MULATTA; MEMBRANE PROTEIN; NEF PROTEIN, SIV; SERINC3 PROTEIN, HUMAN; SERINC5 PROTEIN, HUMAN; TUMOR PROTEIN; VIRAL PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DOWN REGULATION; EPITOPE MAPPING; IMMUNE ESCAPE; IMMUNITY; IMMUNOMODULATION; LYMPHOCYTE FUNCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RHESUS MONKEY; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS REPLICATION; ANIMAL; EVOLUTION; GENETICS; HUMAN; IMMUNE EVASION; IMMUNOLOGY; MACACA; METABOLISM; MUTATION; PATHOGENICITY; SEQUENCE ANALYSIS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIROLOGY;

ANIMALS; BIOLOGICAL EVOLUTION; BONE MARROW STROMAL ANTIGEN 2; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNE EVASION; MACACA; MEMBRANE PROTEINS; MUTATION; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; NEOPLASM PROTEINS; RECEPTORS, CELL SURFACE; RNA, VIRAL; SEQUENCE ANALYSIS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL ENVELOPE PROTEINS; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRUS REPLICATION;

EID: 85042035725     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01822-17     Document Type: Article

References (87)

1. Carrington M, O'Brien S. 2003. The influence of HLA genotype on AIDS. Annu Rev Med 54:535-551. https://doi.org/10.1146/annurev .med.54.101601.152346
2. Goulder P, Watkins D. 2008. Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat Rev Immunol 8:619-630. https://doi.org/10.1038/nri2357
3. Goulder P, Watkins D. 2004. HIV and SIV CTL escape: implications for vaccine design. Nat Rev Immunol 4:630-640. https://doi.org/10.1038/ nri1417
4. O'Connor D, Allen T, Vogel T, Jing P, DeSouza I, Dodds E, Dunphy E, Melsaether C, Mothe B, Yamamoto H, Horton H, Wilson N, Hughes A, Watkins D. 2002. Acute-phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection. Nat Med 8:493-499. https://doi.org/10.1038/nm0502-493
5. Goulder P, Phillips R, Colbert R, McAdam S, Ogg G, Nowak M, Giangrande P, Luzzi G, Morgan B, Edwards A, McMichael A, Rowland-Jones S. 1997. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 3:212-217. https:// doi.org/10.1038/nm0297-212
6. Goepfert P, Lumm W, Farmer P, Matthews P, Prendergast A, Carlson J, Derdeyn C, Tang J, Kaslow R, Bansal A, Yusim K, Heckerman D, Mulenga J, Allen S, Goulder P, Hunter E. 2008. Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients. J Exp Med 205:1009-1017. https://doi.org/10.1084/jem.20072457
7. Feeney M, Tang Y, Roosevelt K, Leslie A, McIntosh K, Karthas N, Walker B, Goulder P. 2004. Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-term-nonprogressing child. J Virol 78:8927-8930. https://doi.org/10.1128/JVI.78.16.8927-8930 .2004
8. Draenert R, Le Gall S, Pfafferott K, Leslie A, Chetty P, Brander C, Holmes E, Chang S, Feeney M, Addo M, Ruiz L, Ramduth D, Jeena P, Altfeld M, Thomas S, Tang Y, Verrill C, Dixon C, Prado J, Kiepiela P, Martinez-Picado J, Walker B, Goulder P. 2004. Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection. J Exp Med 199: 905-915. https://doi.org/10.1084/jem.20031982
9. Crawford H, Prado J, Leslie A, Hue S, Honeyborne I, Reddy S, van der Stok M, Mncube Z, Brander C, Rousseau C, Mullins J, Kaslow R, Goepfert P, Allen S, Hunter E, Mulenga J, Kiepiela P, Walker B, Goulder P. 2007. Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection. J Virol 81:8346-8351. https://doi.org/10.1128/JVI.00465-07
10. Carlson JM, Listgarten J, Pfeifer N, Tan V, Kadie C, Walker BD, Ndung'u T, Shapiro R, Frater J, Brumme ZL, Goulder PJ, Heckerman D. 2012. Widespread impact of HLA restriction on immune control and escape pathways of HIV-1. J Virol 86:5230-5243. https://doi.org/10.1128/JVI.06728-11
11. Evans D, O'Connor D, Jing P, Dzuris J, Sidney J, da Silva J, Allen T, Horton H, Venham J, Rudersdorf R, Vogel T, Pauza C, Bontrop R, DeMars R, Sette A, Hughes A, Watkins D. 1999. Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef. Nat Med 5:1270-1276. https://doi.org/10.1038/15224
12. Loffredo J, Friedrich T, Leon E, Stephany J, Rodrigues D, Spencer S, Bean A, Beal D, Burwitz B, Rudersdorf R, Wallace L, Piaskowski S, May G, Sidney J, Gostick E, Wilson N, Price D, Kallas E, Piontkivska H, Hughes A, Sette A, Watkins D. 2007. CD8+ T cells from SIV elite controller macaques recognize Mamu-B*08-bound epitopes and select for widespread viral variation. PLoS One 2:e1152. https://doi.org/10.1371/journal.pone.0001152
13. Maness N, Valentine L, May G, Reed J, Piaskowski S, Soma T, Furlott J, Rakasz E, Friedrich T, Price D, Gostick E, Hughes A, Sidney J, Sette A, Wilson N, Watkins D. 2007. AIDS virus-specific CD8+ T lymphocytes against an immunodominant cryptic epitope select for viral escape. J Exp Med 204:2505-2512. https://doi.org/10.1084/jem.20071261
14. Maness N, Yant L, Chung C, Loffredo J, Friedrich T, Piaskowski S, Furlott J, May G, Soma T, Leon E, Wilson N, Piontkivska H, Hughes A, Sidney J, Sette A, Watkins D. 2008. Comprehensive immunological evaluation reveals surprisingly few differences between elite controller and progressor Mamu-B*17-positive simian immunodeficiency virus-infected rhesus macaques. J Virol 82:5245-5254. https://doi.org/10.1128/JVI .00292-08
15. Mudd P, Ericsen A, Burwitz B, Wilson N, O'Connor D, Hughes A, Watkins D. 2012. Escape from CD8+ T cell responses in Mamu-B*00801+ macaques differentiates progressors from elite controllers. J Immunol 188: 3364-3370. https://doi.org/10.4049/jimmunol.1102470
16. O'Connor D, McDermott A, Krebs K, Dodds E, Miller J, Gonzalez E, Jacoby T, Yant L, Piontkivska H, Pantophlet R, Burton D, Rehrauer W, Wilson N, Hughes A, Watkins D. 2004. A dominant role for CD8+-T-lymphocyte selection in simian immunodeficiency virus sequence variation. J Virol 78:14012-14022. https://doi.org/10.1128/JVI.78.24.14012-14022.2004
17. Allen T, Altfeld M, Geer S, Kalife E, Moore C, O'sullivan K, Desouza I, Feeney M, Eldridge R, Maier E, Kaufmann D, Lahaie M, Reyor L, Tanzi G, Johnston M, Brander C, Draenert R, Rockstroh J, Jessen H, Rosenberg E, Mallal S, Walker B. 2005. Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution. J Virol 79:13239-13249. https://doi.org/10.1128/JVI.79.21.13239-13249 .2005
18. Kelleher A, Long C, Holmes E, Allen R, Wilson J, Conlon C, Workman C, Shaunak S, Olson K, Goulder P, Brander C, Ogg G, Sullivan J, Dyer W, Jones I, McMichael A, Rowland-Jones S, Phillips R. 2001. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J Exp Med 193:375-386. https://doi.org/10.1084/jem.193.3.375
19. Leslie A, Pfafferott K, Chetty P, Draenert R, Addo M, Feeney M, Tang Y, Holmes E, Allen T, Prado J, Altfeld M, Brander C, Dixon C, Ramduth D, Jeena P, Thomas S, St John A, Roach T, Kupfer B, Luzzi G, Edwards A, Taylor G, Lyall H, Tudor-Williams G, Novelli V, Martinez-Picado J, Kiepiela P, Walker B, Goulder P. 2004. HIV evolution: CTL escape mutation and reversion after transmission. Nat Med 10:282-289. https://doi.org/10 .1038/nm992
20. Martinez-Picado J, Prado J, Fry E, Pfafferott K, Leslie A, Chetty S, Thobakgale C, Honeyborne I, Crawford H, Matthews P, Pillay T, Rousseau C, Mullins J, Brander C, Walker B, Stuart D, Kiepiela P, Goulder P. 2006. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J Virol 80:3617-3623. https:// doi.org/10.1128/JVI.80.7.3617-3623.2006
21. Matthews P, Prendergast A, Leslie A, Crawford H, Payne R, Rousseau C, Rolland M, Honeyborne I, Carlson J, Kadie C, Brander C, Bishop K, Mlotshwa N, Mullins J, Coovadia H, Ndung'u T, Walker B, Heckerman D, Goulder P. 2008. Central role of reverting mutations in HLA associations with human immunodeficiency virus set point. J Virol 82:8548-8559. https://doi.org/10.1128/JVI.00580-08
22. Wright JK, Naidoo VL, Brumme ZL, Prince JL, Claiborne DT, Goulder PJ, Brockman MA, Hunter E, Ndung'u T. 2012. Impact of HLA-B*81-associated mutations in HIV-1 Gag on viral replication capacity. J Virol 86:3193-3199. https://doi.org/10.1128/JVI.06682-11
23. Friedrich TC, Dodds EJ, Yant LJ, Vojnov L, Rudersdorf R, Cullen C, Evans DT, Desrosiers RC, Mothe BR, Sidney J, Sette A, Kunstman K, Wolinsky S, Piatak M, Lifson J, Hughes AL, Wilson N, O'Connor DH, Watkins DI. 2004. Reversion of CTL escape-variant immunodeficiency viruses in vivo. Nat Med 10:275-281. https://doi.org/10.1038/nm998
24. Friedrich TC, Frye CA, Yant LJ, O'Connor DH, Kriewaldt NA, Benson M, Vojnov L, Dodds EJ, Cullen C, Rudersdorf R, Hughes AL, Wilson N, Watkins DI. 2004. Extraepitopic compensatory substitutions partially restore fitness to simian immunodeficiency virus variants that escape from an immunodominant cytotoxic-T-lymphocyte response. J Virol 78: 2581-2585. https://doi.org/10.1128/JVI.78.5.2581-2585.2004
25. Kiepiela P, Ngumbela K, Thobakgale C, Ramduth D, Honeyborne I, Moodley E, Reddy S, de Pierres C, Mncube Z, Mkhwanazi N, Bishop K, van der Stok M, Nair K, Khan N, Crawford H, Payne R, Leslie A, Prado J, Prendergast A, Frater J, McCarthy N, Brander C, Learn G, Nickle D, Rousseau C, Coovadia H, Mullins J, Heckerman D, Walker B, Goulder P. 2007. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 13:46-53. https://doi.org/10.1038/ nm1520
26. Brockman MA, Brumme ZL, Brumme CJ, Miura T, Sela J, Rosato PC, Kadie CM, Carlson JM, Markle TJ, Streeck H, Kelleher AD, Markowitz M, Jessen H, Rosenberg E, Altfeld M, Harrigan PR, Heckerman D, Walker BD, Allen TM. 2010. Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection. J Virol 84:11937-11949. https://doi.org/10.1128/JVI .01086-10
27. Brumme ZL, Tao I, Szeto S, Brumme CJ, Carlson JM, Chan D, Kadie C, Frahm N, Brander C, Walker B, Heckerman D, Harrigan PR. 2008. Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection. AIDS 22:1277-1286. https://doi.org/10.1097/QAD.0b013e3283021a8c
28. Julg B, Williams K, Reddy S, Bishop K, Qi Y, Carrington M, Goulder P, Ndung'u T, Walker B. 2010. Enhanced anti-HIV functional activity associated with Gag-specific CD8 T-cell responses. J Virol 84:5540-5549. https://doi.org/10.1128/JVI.02031-09
29. Kloverpris H, Payne R, Sacha J, Rasaiyaah J, Chen F, Takiguchi M, Yang O, Towers G, Goulder P, Prado J. 2013. Early antigen presentation of protective HIV-1 KF11Gag and KK10Gag epitopes from incoming viral particles facilitates rapid recognition of infected cells by specific CD8+ T cells. J Virol 87:2628-2638. https://doi.org/10.1128/JVI.02131-12
30. Payne RP, Kloverpris H, Sacha JB, Brumme Z, Brumme C, Buus S, Sims S, Hickling S, Riddell L, Chen F, Luzzi G, Edwards A, Phillips R, Prado JG, Goulder PJ. 2010. Efficacious early antiviral activity of HIV Gag-and Pol-specific HLA-B 2705-restricted CD8+ T cells. J Virol 84:10543-10557. https://doi.org/10.1128/JVI.00793-10
31. Schneidewind A, Brockman M, Yang R, Adam R, Li B, Le Gall S, Rinaldo C, Craggs S, Allgaier R, Power K, Kuntzen T, Tung C, LaBute M, Mueller S, Harrer T, McMichael A, Goulder P, Aiken C, Brander C, Kelleher A, Allen T. 2007. Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. J Virol 81: 12382-12393. https://doi.org/10.1128/JVI.01543-07
32. Loffredo J, Bean A, Beal D, Leon E, May G, Piaskowski S, Furlott J, Reed J, Musani S, Rakasz E, Friedrich T, Wilson N, Allison D, Watkins D. 2008. Patterns of CD8+ immunodominance may influence the ability of Mamu-B*08-positive macaques to naturally control simian immunodeficiency virus SIVmac239 replication. J Virol 82:1723-1738. https://doi .org/10.1128/JVI.02084-07
33. Loffredo J, Sidney J, Bean A, Beal D, Bardet W, Wahl A, Hawkins O, Piaskowski S, Wilson N, Hildebrand W, Watkins D, Sette A. 2009. Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity. J Immunol 182:7763-7775. https://doi.org/10.4049/ jimmunol.0900111
34. Mothe B, Sidney J, Dzuris J, Liebl M, Fuenger S, Watkins D, Sette A. 2002. Characterization of the peptide-binding specificity of Mamu-B*17 and identification of Mamu-B*17-restricted epitopes derived from simian immunodeficiency virus proteins. J Immunol 169:210-219. https://doi .org/10.4049/jimmunol.169.1.210
35. Mudd P, Martins M, Ericsen A, Tully D, Power K, Bean A, Piaskowski S, Duan L, Seese A, Gladden A, Weisgrau K, Furlott J, Kim Y, Veloso de Santana M, Rakasz E, Iii S, Wilson N, Bonaldo M, Galler R, Allison D, Piatak M, Jr, Haase A, Lifson J, Allen T, Watkins D. 2012. Vaccine-induced CD8+ T cells control AIDS virus replication. Nature 491:129-133. https://doi .org/10.1038/nature11443
36. Frahm N, Adams S, Kiepiela P, Linde C, Hewitt H, Lichterfeld M, Sango K, Brown N, Pae E, Wurcel A, Altfeld M, Feeney M, Allen T, Roach T, St John M, Daar E, Rosenberg E, Korber B, Marincola F, Walker B, Goulder P, Brander C. 2005. HLA-B63 presents HLA-B57/B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus load. J Virol 79:10218-10225. https://doi.org/10.1128/JVI.79 .16.10218-10225.2005
37. Chakraborty S, Rahman T, Chakravorty R. 2014. Characterization of the protective HIV-1 CTL epitopes and the corresponding HLA class I alleles: a step towards designing a CTL-based HIV-1 vaccine. Adv Virol 2014: 321974. https://doi.org/10.1155/2014/321974
38. Mann JK, Byakwaga H, Kuang XT, Le AQ, Brumme CJ, Mwimanzi P, Omarjee S, Martin E, Lee GQ, Baraki B, Danroth R, McCloskey R, Muzoora C, Bangsberg DR, Hunt PW, Goulder PJ, Walker BD, Harrigan PR, Martin JN, Ndung'u T, Brockman MA, Brumme ZL. 2013. Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes. Retrovirology 10:100. https://doi.org/10.1186/1742-4690-10-100
39. Mwimanzi P, Markle TJ, Martin E, Ogata Y, Kuang XT, Tokunaga M, Mahiti M, Pereyra F, Miura T, Walker BD, Brumme ZL, Brockman MA, Ueno T. 2013. Attenuation of multiple Nef functions in HIV-1 elite controllers. Retrovirology 10:1. https://doi.org/10.1186/1742-4690-10-1
40. Adland E, Carlson JM, Paioni P, Kloverpris H, Shapiro R, Ogwu A, Riddell L, Luzzi G, Chen F, Balachandran T, Heckerman D, Stryhn A, Edwards A, Ndung'u T, Walker BD, Buus S, Goulder P, Matthews PC. 2013. Nefspecific CD8+ T cell responses contribute to HIV-1 immune control. PLoS One 8:e73117. https://doi.org/10.1371/journal.pone.0073117
41. Salgado M, Brennan T, O'Connell K, Bailey J, Ray S, Siliciano R, Blankson J. 2010. Evolution of the HIV-1 nef gene in HLA-B*57 positive elite suppressors. Retrovirology 7:94. https://doi.org/10.1186/1742-4690-7-94
42. Budde ML, Greene JM, Chin EN, Ericsen AJ, Scarlotta M, Cain BT, Pham NH, Becker EA, Harris M, Weinfurter JT, O'Connor SL, Piatak M, Jr, Lifson JD, Gostick E, Price DA, Friedrich TC, O'Connor DH. 2012. Specific CD8+ T cell responses correlate with control of simian immunodeficiency virus replication in Mauritian cynomolgus macaques. J Virol 86:7596-7604. https://doi.org/10.1128/JVI.00716-12
43. Khalid M, Yu H, Sauter D, Usmani S, Schmokel J, Feldman J, Gruters R, van der Ende M, Geyer M, Rowland-Jones S, Osterhaus A, Kirchhoff F. 2012. Efficient Nef-mediated downmodulation of TCR-CD3 and CD28 is associated with high CD4+ T cell counts in viremic HIV-2 infection. J Virol 86:4906-4920. https://doi.org/10.1128/JVI.06856-11
44. Ilyinskii PO, Daniel MD, Simon MA, Lackner AA, Desrosiers RC. 1994. The role of upstream U3 sequences in the pathogenesis of simian immunodeficiency virus-induced AIDS in rhesus monkeys. J Virol 68:5933-5944
45. Garcia JV, Miller AD. 1991. Serine phosphorylation-independent downregulation of cell surface CD4 by nef. Nature 350:508-511. https://doi .org/10.1038/350508a0
46. Foster JL, Anderson SJ, Frazier AL, Garcia JV. 1994. Specific suppression of human CD4 surface expression by Nef from the pathogenic simian immunodeficiency virus SIVmac239open. Virology 201:373-379. https:// doi.org/10.1006/viro.1994.1303
47. Heigele A, Schindler M, Gnanadurai C, Leonard J, Collins K, Kirchhoff F. 2012. Down-modulation of CD8αβ is a fundamental activity of primate lentiviral Nef proteins. J Virol 86:36-48. https://doi.org/10 .1128/JVI.00717-11
48. Bell I, Schaefer TM, Trible RP, Amedee A, Reinhart TA. 2001. Down-modulation of the costimulatory molecule, CD28, is a conserved activity of multiple SIV Nefs and is dependent on histidine 196 of Nef. Virology 283:148-158. https://doi.org/10.1006/viro.2001.0872
49. Zhang F, Wilson SJ, Landford WC, Virgen B, Gregory D, Johnson MC, Munch J, Kirchhoff F, Bieniasz PD, Hatziioannou T. 2009. Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe 6:54-67. https://doi.org/10.1016/j.chom.2009.05.008
50. Jia B, Serra-Moreno R, Neidermyer W, Rahmberg A, Mackey J, Fofana I, Johnson W, Westmoreland S, Evans D. 2009. Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by Tetherin/BST2. PLoS Pathog 5:e1000429. https://doi.org/10.1371/journal.ppat.1000429
51. Schwartz O, Marechal V, Le Gall S, Lemonnier F, Heard J. 1996. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med 2:338-342. https://doi .org/10.1038/nm0396-338
52. Stumptner-Cuvelette P, Morchoisne S, Dugast M, Le Gall S, Raposo G, Schwartz O, Benaroch P. 2001. HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc Natl Acad Sci U S A 98: 12144-12149. https://doi.org/10.1073/pnas.221256498
53. Chen N, McCarthy C, Drakesmith H, Li D, Cerundolo V, McMichael A, Screaton G, Xu X. 2006. HIV-1 downregulates the expression of CD1d via Nef. Eur J Immunol 36:278-286. https://doi.org/10.1002/eji.200535487
54. Chaudhry A, Das S, Hussain A, Mayor S, George A, Bal V, Jameel S, Rath S. 2005. The Nef protein of HIV-1 induces loss of cell surface costimulatory molecules CD80 and CD86 in APCs. J Immunol 175:4566-4574. https://doi.org/10.4049/jimmunol.175.7.4566
55. Trautz B, Pierini V, Wombacher R, Stolp B, Chase AJ, Pizzato M, Fackler OT. 2016. The antagonism of HIV-1 Nef to SERINC5 particle infectivity restriction involves the counteraction of virion-associated pools of the restriction factor. J Virol 90:10915-10927. https://doi.org/10.1128/JVI .01246-16
56. Usami Y, Wu Y, Gottlinger HG. 2015. SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef. Nature 526:218-223. https://doi .org/10.1038/nature15400
57. Rosa A, Chande A, Ziglio S, De Sanctis V, Bertorelli R, Goh SL, McCauley SM, Nowosielska A, Antonarakis SE, Luban J, Santoni FA, Pizzato M. 2015. HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation. Nature 526:212-217. https://doi.org/10.1038/nature15399
58. Matheson NJ, Sumner J, Wals K, Rapiteanu R, Weekes MP, Vigan R, Weinelt J, Schindler M, Antrobus R, Costa AS, Frezza C, Clish CB, Neil SJ, Lehner PJ. 2015. Cell surface proteomic map of HIV infection reveals antagonism of amino acid metabolism by Vpu and Nef. Cell Host Microbe 18:409-423. https://doi.org/10.1016/j.chom.2015.09.003
59. Greenberg M, Bronson S, Lock M, Neumann M, Pavlakis G, Skowronski J. 1997. Colocalization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 downregulation. EMBO J 16: 6964-6976. https://doi.org/10.1093/emboj/16.23.6964
60. Swigut T, Shohdy N, Skowronski J. 2001. Mechanism for down-regulation of CD28 by Nef. EMBO J 20:1593-1604. https://doi.org/10.1093/emboj/ 20.7.1593
61. Brenner M, Munch J, Schindler M, Wildum S, Stolte N, Stahl-Hennig C, Fuchs D, Matz-Rensing K, Franz M, Heeney J, Ten Haaft P, Swigut T, Hrecka K, Skowronski J, Kirchhoff F. 2006. Importance of the N-distal AP-2 binding element in Nef for simian immunodeficiency virus replication and pathogenicity in rhesus macaques. J Virol 80:4469-4481. https://doi.org/10.1128/JVI.80.9.4469-4481.2006
62. Zhang F, Landford W, Ng M, McNatt M, Bieniasz P, Hatziioannou T. 2011. SIV Nef proteins recruit the AP-2 complex to antagonize Tetherin and facilitate virion release. PLoS Pathog 7:e1002039. https://doi.org/10 .1371/journal.ppat.1002039
63. Ren X, Park SY, Bonifacino JS, Hurley JH. 2014. How HIV-1 Nef hijacks the AP-2 clathrin adaptor to downregulate CD4. Elife 3:e01754. https://doi .org/10.7554/eLife.01754
64. Serra-Moreno R, Zimmermann K, Stern L, Evans D. 2013. Tetherin/BST-2 antagonism by Nef depends on a direct physical interaction between Nef and tetherin, and on clathrin-mediated endocytosis. PLoS Pathog 9:e1003487. https://doi.org/10.1371/journal.ppat.1003487
65. Lindwasser OW, Smith WJ, Chaudhuri R, Yang P, Hurley JH, Bonifacino JS. 2008. A diacidic motif in human immunodeficiency virus type 1 Nef is a novel determinant of binding to AP-2. J Virol 82:1166-1174. https://doi .org/10.1128/JVI.01874-07
66. Arias JF, Heyer LN, von Bredow B, Weisgrau KL, Moldt B, Burton DR, Rakasz EG, Evans DT. 2014. Tetherin antagonism by Vpu protects HIVinfected cells from antibody-dependent cell-mediated cytotoxicity. Proc Natl Acad Sci U S A 111:6425-6430. https://doi.org/10.1073/pnas .1321507111
67. Arias JF, Colomer-Lluch M, von Bredow B, Greene JM, MacDonald J, O'Connor DH, Serra-Moreno R, Evans DT. 2016. Tetherin antagonism by HIV-1 group M Nef proteins. J Virol https://doi.org/10.1128/JVI.01465-16
68. von Bredow B, Arias JF, Heyer LN, Gardner MR, Farzan M, Rakasz EG, Evans DT. 2015. Envelope glycoprotein internalization protects human and simian immunodeficiency virus-infected cells from antibodydependent cell-mediated cytotoxicity. J Virol 89:10648-10655. https:// doi.org/10.1128/JVI.01911-15
69. Weiler AM, Das A, Akinyosoye O, Cui S, O'Connor SL, Scheef EA, Reed JS, Panganiban AT, Sacha JB, Rakasz EG, Friedrich TC, Maness NJ. 2016. Acute viral escape selectively impairs Nef-mediated major histocompatibility complex class I downmodulation and increases susceptibility to antiviral T cells. J Virol 90:2119-2126. https://doi .org/10.1128/JVI.01975-15
70. Wilker PR, Dinis JM, Starrett G, Imai M, Hatta M, Nelson CW, O'Connor DH, Hughes AL, Neumann G, Kawaoka Y, Friedrich TC. 2013. Selection on haemagglutinin imposes a bottleneck during mammalian transmission of reassortant H5N1 influenza viruses. Nat Commun 4:2636. https://doi .org/10.1038/ncomms3636
71. O'Doherty U, Swiggard W, Malim M. 2000. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J Virol 74:10074-10080. https://doi.org/10.1128/JVI.74.21.10074-10080.2000
72. Chaudhuri R, Lindwasser OW, Smith WJ, Hurley JH, Bonifacino JS. 2007. Downregulation of CD4 by human immunodeficiency virus type 1 Nef is dependent on clathrin and involves direct interaction of Nef with the AP2 clathrin adaptor. J Virol 81:3877-3890. https://doi.org/10.1128/JVI .02725-06
73. Rodionov DG, Honing S, Silye A, Kongsvik TL, von Figura K, Bakke O. 2002. Structural requirements for interactions between leucine-sorting signals and clathrin-associated adaptor protein complex AP3. J Biol Chem 277:47436-47443. https://doi.org/10.1074/jbc.M207149200
74. Prado J, Honeyborne I, Brierley I, Puertas M, Martinez-Picado J, Goulder P. 2009. Functional consequences of human immunodeficiency virus escape from an HLA-B*13-restricted CD8+ T-cell epitope in p1 Gag protein. J Virol 83:1018-1025. https://doi.org/10.1128/JVI.01882-08
75. Wang Y, Li B, Carlson J, Streeck H, Gladden A, Goodman R, Schneidewind A, Power K, Toth I, Frahm N, Alter G, Brander C, Carrington M, Walker B, Altfeld M, Heckerman D, Allen T. 2008. Protective HLA class I alleles restricting acute-phase CD8+ T cell responses are associated with viral escape mutations located in highly conserved regions of HIV-1. J Virol 83:1845-1855. https://doi.org/10.1128/JVI.01061-08
76. Heigele A, Kmiec D, Regensburger K, Langer S, Peiffer L, Sturzel CM, Sauter D, Peeters M, Pizzato M, Learn GH, Hahn BH, Kirchhoff F. 2016. The potency of Nef-mediated SERINC5 antagonism correlates with the prevalence of primate lentiviruses in the wild. Cell Host Microbe 20: 381-391. https://doi.org/10.1016/j.chom.2016.08.004
77. Lauck M, Switzer WM, Sibley SD, Hyeroba D, Tumukunde A, Weny G, Shankar A, Greene JM, Ericsen AJ, Zheng H, Ting N, Chapman CA, Friedrich TC, Goldberg TL, O'Connor DH. 2014. Discovery and full genome characterization of a new SIV lineage infecting red-tailed guenons (Cercopithecus ascanius schmidti) in Kibale National Park, Uganda. Retrovirology 11:55. https://doi.org/10.1186/1742-4690-11-55
78. Bimber B, Dudley D, Lauck M, Becker E, Chin E, Lank S, Grunenwald H, Caruccio N, Maffitt M, Wilson N, Reed J, Sosman J, Tarosso L, Sanabani S, Kallas E, Hughes A, O'Connor D. 2010. Whole-genome characterization of human and simian immunodeficiency virus intrahost diversity by ultradeep pyrosequencing. J Virol 84:12087-12092. https://doi.org/10 .1128/JVI.01378-10
79. Clack NG, O'Connor DH, Huber D, Petreanu L, Hires A, Peron S, Svoboda K, Myers EW. 2012. Automated tracking of whiskers in videos of head fixed rodents. PLoS Comput Biol 8:e1002591. https://doi.org/10.1371/ journal.pcbi.1002591
80. Wilson N, Reed J, Napoe G, Piaskowski S, Szymanski A, Furlott J, Gonzalez E, Yant L, Maness N, May G, Soma T, Reynolds M, Rakasz E, Rudersdorf R, McDermott A, O'Connor D, Friedrich T, Allison D, Patki A, Picker L, Burton D, Lin J, Huang L, Patel D, Heindecker G, Fan J, Citron M, Horton M, Wang F, Liang X, Shiver J, Casimiro D, Watkins D. 2006. Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239. J Virol 80: 5875-5885. https://doi.org/10.1128/JVI.00171-06
81. + T lymphocyte response against an out-of-frame epitope. J Immunol 184:67-72. https://doi.org/10.4049/ jimmunol.0903118
82. Sacha J, Watkins D. 2010. Synchronous infection of SIV and HIV in vitro for virology, immunology and vaccine-related studies. Nat Protoc 5:239-246. https://doi.org/10.1038/nprot.2009.227
83. Yuste E, Reeves JD, Doms RW, Desrosiers RC. 2004. Modulation of Env content in virions of simian immunodeficiency virus: correlation with cell surface expression and virion infectivity. J Virol 78:6775-6785. https:// doi.org/10.1128/JVI.78.13.6775-6785.2004
84. Postler TS, Bixby JG, Desrosiers RC, Yuste E. 2014. Systematic analysis of intracellular trafficking motifs located within the cytoplasmic domain of simian immunodeficiency virus glycoprotein gp41. PLoS One 9:e114753. https://doi.org/10.1371/journal.pone.0114753
85. Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. 2013. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29:15-21. https://doi.org/10.1093/bioinformatics/bts635
86. Li B, Dewey C. 2011. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12:323. https://doi.org/10.1186/1471-2105-12-323
87. Monjure CJ, Tatum CD, Panganiban AT, Arainga M, Traina-Dorge V, Marx PA, Jr, Didier ES. 2014. Optimization of PCR for quantification of simian immunodeficiency virus genomic RNA in plasma of rhesus macaques (Macaca mulatta) using armored RNA. J Med Primatol 43:31-43. https:// doi.org/10.1111/jmp.12088